RPRX: Royalty Pharma plc - Class A
今日RPRX汇率已更改1.95%。当日,交易品种以低点56.90和高点58.44进行交易。
关注Royalty Pharma plc - Class A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RPRX新闻
- ImmunityBio: Revisiting My Bearish Call After A 250% Rise (Upgrade) (NASDAQ:IBRX)
- Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- A Fresh Look At Syndax Pharmaceuticals (NASDAQ:SNDX)
- Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Why Royalty Pharma (RPRX) Could Beat Earnings Estimates Again
- Are You Looking for a Top Momentum Pick? Why Royalty Pharma (RPRX) is a Great Choice
- Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run?
- Broadcom Inks Pact With Meta, Leads 21 Top Performers Onto Best Stock Watchlists
- RPRX or ACAD: Which Is the Better Value Stock Right Now?
- Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists
- Arista Networks, Morgan Stanley Among 15 New Stocks On IBD Watchlists
- GE Aerospace Hits Record High, Leads 19 Onto IBD 50, Big Cap 20, Other Best Stock Lists
- Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition - Theravance Biopharma (NASDAQ
- A New All-Time High, an 81% Overnight Gain, and One "Forever Stock"
- Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade) (VRTX)
- Three “Forever Stocks” for the AI Age
- Why Is Agenus (AGEN) Down 9.6% Since Last Earnings Report?
- Royalty Pharma plc (RPRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- GSK to Strengthen Oncology Pipeline With $10.6B Nuvalent Buyout
- Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
- Royalty Pharma plc (RPRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
- Royalty Pharma Stock: Strong Execution, Expanding Pipeline And More Firepower Ahead (RPRX)
- Dividend Champion, Contender, And Challenger Highlights: Week Of May 10
- RPRX vs. AMGN: Which Stock Is the Better Value Option?
常见问题解答
RPRX股票今天的价格是多少?
Royalty Pharma plc - Class A股票今天的定价为58.42。它在56.90 - 58.44范围内交易,昨天的收盘价为57.30,交易量达到6199。RPRX的实时价格图表显示了这些更新。
Royalty Pharma plc - Class A股票是否支付股息?
Royalty Pharma plc - Class A目前的价值为58.42。股息政策取决于公司,而投资者也会关注56.79%和USD。实时查看图表以跟踪RPRX走势。
如何购买RPRX股票?
您可以以58.42的当前价格购买Royalty Pharma plc - Class A股票。订单通常设置在58.42或58.72附近,而6199和2.10%显示市场活动。立即关注RPRX的实时图表更新。
如何投资RPRX股票?
投资Royalty Pharma plc - Class A需要考虑年度范围35.92 - 59.44和当前价格58.42。许多人在以58.42或58.72下订单之前,会比较4.15%和。实时查看RPRX价格图表,了解每日变化。
Royalty Pharma plc - Class A股票的最高价格是多少?
在过去一年中,Royalty Pharma plc - Class A的最高价格是59.44。在35.92 - 59.44内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Royalty Pharma plc - Class A的绩效。
Royalty Pharma plc - Class A股票的最低价格是多少?
Royalty Pharma plc - Class A(RPRX)的最低价格为35.92。将其与当前的58.42和35.92 - 59.44进行比较,可以发现潜在的长期切入点。观看RPRX在图表上的实时走势以获取更多详细信息。
RPRX股票是什么时候拆分的?
Royalty Pharma plc - Class A历史上曾经历过股票拆分。这些变化在公司行动后的、57.30和56.79%中可见。
- 前一天收盘价
- 57.30
- 开盘价
- 57.22
- 卖价
- 58.42
- 买价
- 58.72
- 最低价
- 56.90
- 最高价
- 58.44
- 交易量
- 6.199 K
- 日变化
- 1.95%
- 月变化
- 4.15%
- 6个月变化
- 40.70%
- 年变化
- 56.79%
- 实际值
- 预测值
- 1.978 M
- 前值
- -1.692 M
- 实际值
- 预测值
- 0.992 M
- 前值
- 0.430 M
- 实际值
- 预测值
- 前值
- 4.927%